Skip to content

Verona Pharma plc

CIK 0001657312

← back to feed
Revenue (TTM)
$185.02M
Q2 Jun 2025
Net Income (TTM)
−$118.2M
−219.0% YoY Q2 Jun 2025
EPS Diluted (TTM)
−$0.18
−200.0% YoY Q2 Jun 2025
Gross Margin
0.0%
Q2 Jun 2025
Operating Margin
-57.3%
Q2 Jun 2025
Net Margin
-63.9%
Q2 Jun 2025
Free Cash Flow (TTM)
−$46.02M
Q2 Jun 2025
Cash
$438.02M
Q2 Jun 2025
Total Debt
$242.43M
Q2 Jun 2025
Shares Outstanding
681.06M sh
Q2 Jun 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings